GeneDx Holdings Corp (NASDAQ: WGS) is -12.59% lower on its value in year-to-date trading and has touched a low of $3.63 and a high of $98.87 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The WGS stock was last observed hovering at around $72.02 in the last trading session, with the day’s loss setting it -4.84%.
Currently trading at $67.18, the stock is -13.25% and -13.31% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.47 million and changing -6.72% at the moment leaves the stock 41.66% off its SMA200. WGS registered 1649.48% gain for a year compared to 6-month gain of 138.35%. The firm has a 50-day simple moving average (SMA 50) of $77.5381 and a 200-day simple moving average (SMA200) of $47.13495.
The stock witnessed a -15.11% loss in the last 1 month and extending the period to 3 months gives it a -13.58%, and is -11.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.74% over the week and 10.45% over the month.
GeneDx Holdings Corp (WGS) has around 1000 employees, a market worth around $1.85B and $267.23M in sales. Fwd P/E is 122.45. Profit margin for the company is -31.25%. Distance from 52-week low is 1750.69% and -32.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.35%).
with sales reaching $82.24M over the same period.The EPS is expected to grow by 94.88% this year, but quarterly earnings will post 43.57% year-over-year. Quarterly sales are estimated to grow 43.23% in year-over-year returns.
203.0 institutions hold shares in GeneDx Holdings Corp (WGS), with institutional investors hold 90.55% of the company’s shares. The shares outstanding are 27.43M, and float is at 22.06M with Short Float at 9.69%. Institutions hold 74.39% of the Float.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 3.53 million shares valued at $92.18 million. The investor’s holdings represent 13.2482 of the WGS Shares outstanding. As of 2024-06-30, the second largest holder is CORVEX MANAGEMENT LP with 2.47 million shares valued at $64.66 million to account for 9.2937 of the shares outstanding. The other top investors are ORACLE INVESTMENT MANAGEMENT INC which holds 1.11 million shares representing 4.1542 and valued at over $28.9 million, while BLACKROCK INC. holds 3.4735 of the shares totaling 0.92 million with a market value of $24.17 million.
GeneDx Holdings Corp (WGS) Insider Activity
The most recent transaction is an insider sale by Feeley Kevin, the company’s CHIEF FINANCIAL OFFICER. SEC filings show that Feeley Kevin sold 275 shares of the company’s common stock on Jan 29 ’25 at a price of $78.48 per share for a total of $21582.0. Following the sale, the insider now owns 2950.0 shares.
GeneDx Holdings Corp disclosed in a document filed with the SEC on Jan 29 ’25 that Stueland Katherine (Chief Executive Officer) sold a total of 1,657 shares of the company’s common stock. The trade occurred on Jan 29 ’25 and was made at $78.48 per share for $0.13 million. Following the transaction, the insider now directly holds 3937.0 shares of the WGS stock.
Still, SEC filings show that on Jan 30 ’25, ICAHN SCHOOL OF MEDICINE AT MO (Stockholder) Proposed Sale 1,346,123 shares at an average price of $77.86 for $104.81 million. The insider now directly holds shares of GeneDx Holdings Corp (WGS).
